Pular para o conteúdo principal

ETHNOS_APP

Início • Busca • Periódicos • Lista 0

Has the treatment gap for opioid use disorder narrowed in the U.S

A yearly assessment from 2010 to 2019”

Dados Bibliográficos

ID17680452
AutoresNoa Krawczyk (0000-0002-7396-3938, New York University, autor correspondente), Bianca D Rivera (0000-0001-9852-511X, New York University), Victoria A Jent (0000-0002-5695-081X, New York University), Katherine M Keyes (0000-0002-5624-021X, Columbia University), Christopher M Jones (0000-0002-6504-6224, Centers for Disease Control and Prevention), Magdalena Cerdá (0000-0001-8441-7046, New York University)
Ano2022
Volume110
Páginas103786-103786
Data de publicação2022-08-04
Peer ReviewedSim
Open AccessSim
TipoARTICLE
PeriódicoInternational Journal of Drug Policy (JOURNAL)
Identificadores do periódicoISSN: 0955-3959 • E-ISSN: 1873-4758
EditoraElsevier BV (PUBLISHER)
DOI10.1016/j.drugpo.2022.103786
PMID35934583
OpenAlexW4289841403
IdiomaEN
Citações recebidas33
Referências citadas26

Despite some progress in expanding access to MOUD, a substantial gap between OUD prevalence and treatment receipt highlights the critical need to increase access to evidence-based services

Business · Environmental health · Family medicine · Health care · Medicaid · Opioid · Opioid use disorder · Political science · Psychiatry · Receipt · Sociology · Specialty · Demography · Law · Medicine · Opioid Use Disorder Treatment · Pharmaceutical Practices and Patient Outcomes · Substance Abuse Treatment and Outcomes

  • Sustaining substance use recovery housing for people taking medications for opioid use disorder

    Open Access•I Niles Zoschke, Kathryn R Gallardo et al.•Frontiers in Public Health•2025

  • The development of a recovery coaching training curriculum to facilitate linkage to and increase retention on medications for opioid use disorder

    Open Access•Trevor Moffitt, Amanda Fallin‐Bennett et al.•Frontiers in Public Health•2024

  • Opioid use disorder

    Open Access•Yu Kyung Lee, Mark S Gold et al.•Frontiers in Public Health•2024

  • People Who Use Illegal Opioids Use of Methadone over Time, and What Characteristics Are Correlated with Staying in Methadone Maintenance Treatment

    David Frank, L Elliott et al.•Substance Use & Misuse•2026

  • Substance Use Monitoring Among People Who Use Drugs Using a Novel Assay to Test Dried Blood Spot Specimens

    Kaitlin A Zinsli, Alex J Krotulski et al.•Substance Use & Misuse•2025

  • Concurrent Use of Extra‐Medical Medication for Opioid Use Disorder Among Adults Prescribed Methadone or Buprenorphine

    Open Access•Kyle J Moon, Becky L Genberg et al.•Drug and Alcohol Review•2026

  • A qualitative study of reasons to use substances and substance use treatment experiences among transgender and gender diverse adults in Rhode Island

    Open Access•Patrick J A Kelly, Paige Myers-Matthews et al.•SSM - Qualitative Research in…•2024

  • Rural and urban differences in treatment on demand for substance use treatment involving medications for opioid use disorder

    Open Access•Ryan J Lofaro, Robert Bohler et al.•The Journal of Rural Health•2025

  • Bridging the gaps

    Open Access•Robert Bohler, Ryan J Lofaro et al.•The Journal of Rural Health•2025

  • Expanding access to low‐barrier opioid use disorder treatment in non‐traditional settings

    Open Access•Shay M Daily, Sharon Reif et al.•The Journal of Rural Health•2026

  • Structural contradictions in providing opioid use disorder care within the total institution of carceral facilities

    Open Access•Ashley Q Truong, Victoria R Green et al.•Social Science & Medicine•2026

  • Identifying Populations with High Opioid Use Disorder Public Stigma

    Open Access•Virginia Brown, Thuy Dung Pham et al.•Community Mental Health Journal•2026

  • Comparing methadone policy and practice in France and the US

    Open Access•Honora Englander, Mathieu Chappuy et al.•International Journal of Drug…•2024

  • Buprenorphine deregulation as an opioid crisis policy response - A comparative analysis between France and the United States

    Open Access•Abhimanyu Sud, Kellia Chiu et al.•International Journal of Drug…•2023

  • Community-level determinants of stakeholder perceptions of community stigma toward people with opioid use disorders, harm reduction services and treatment in the Healing Communities Study

    Open Access•Alissa Davis, Kristi L Stringer et al.•International Journal of Drug…•2023

  • Network Analysis of Medical Claims Data Suggests Network-Based, Regional Targeting and Intervention Delivery Strategies to Increase Access to Office Based Opioid Treatment (Obot) for Opioid Use Disorder (OUD)

    Open Access•Helena D Green, Patrick Kaminski et al.•INQUIRY The Journal of Health…•2024

  • Using Evidence to Inform Legislation Aimed at Curbing Fentanyl Deaths

    Open Access•Cole Jurecka, Cole A Jurecka et al.•JAMA Health Forum•2023

  • State Prior Authorization Prohibitions and Buprenorphine Retention Among Privately Insured Patients

    Open Access•Ju-Chen Hu, Shashi N Kapadia et al.•JAMA Health Forum•2026

  • State- and County-Level Geographic Variation in Opioid Use Disorder, Medication Treatment, and Opioid-Related Overdose Among Medicaid Enrollees

    Open Access•Stephan Lindner, Kyle D Hart et al.•JAMA Health Forum•2023

  • Characteristics and Prescribing Patterns of Clinicians Waivered to Prescribe Buprenorphine for Opioid Use Disorder Before and After Release of New Practice Guidelines

    Open Access•Christopher M Jones, Yngvild Olsen et al.•JAMA Health Forum•2023

  • Adaptable Tool for Modeling the Benefits and Costs of Substance Use Disorder Recovery Programs

    Open Access•Madison Ashworth, David P Johnson et al.•Journal of Benefit-Cost Analysis•2024

  • Exploring passion for opioid use with a treatment-seeking sample

    Brandon Park, A K Davis et al.•Addiction Research & Theory•2025

  • Allocative efficiency analysis of strategies to reduce overdose deaths among people with opioid use disorder and history of incarceration in Connecticut

    Open Access•Joy D Scheidell, Jillian M Frechette et al.•BMC Public Health•2025

  • Typology of laws restricting access to methadone treatment in the United States

    Open Access•Anne Conway, Noa Krawczyk et al.•International Journal of Drug…•2023

  • Retention and dropout from sublingual and extended-release buprenorphine treatment

    Open Access•Roman Ivasiy, Lynn Madden et al.•International Journal of Drug…•2025

  • Mortality, incarceration and cost implications of fentanyl felonization laws

    Open Access•Alexandra Savinkina, Cole Jurecka et al.•International Journal of Drug…•2023

  • Get in and get out, get on with life”

    Open Access•Leslie W Suen, Scott Steiger et al.•International Journal of Drug…•2023

  • Simulated impact of medicaid expansion on the economic burden of opioid use disorder in North Carolina

    Open Access•Carolina Barbosa, William N Dowd et al.•International Journal of Drug…•2024

  • Integration of substance use disorder treatment in traditional mental health facilities

    Open Access•Yunkyoung Loh Garrison, Yan Luo et al.•International Journal of Drug…•2024

  • When profit meets public health

    Open Access•Victor Roy, Benjamin A Barsky et al.•International Journal of Drug…•2026

  • Examining the association between county racialised economic segregation and fatal overdose in US counties, 2018–2022

    Samantha M Doonan, Spruha Joshi et al.•Journal of Epidemiology and…•2026

  • Federal Impacts on Buprenorphine Prescribing in Washington State, 2012 to 2022

    Fan Xiong, Jillian Jetson et al.•American Journal of Public Health•2024

  • A Spatial Epidemiologic Analysis of Opioid Use Disorder Treatment in New York State

    Ashly E Jordan, Weihui Zhang et al.•Medical Care•2025

  • The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement

    Open Access•Erik Von Elm, David G Altman et al.•Bulletin of the World Health…•2007

  • Association of Opioid Agonist Treatment With All-Cause Mortality and Specific Causes of Death Among People With Opioid Dependence

    Thomas Santo, Brodie Clark et al.•JAMA Psychiatry•2021

  • National and State Treatment Need and Capacity for Opioid Agonist Medication-Assisted Treatment

    Christopher M Jones, Melinda Campopiano et al.•American Journal of Public Health•2015

  • Estimated Prevalence of Opioid Use Disorder in Massachusetts, 2011–2015

    Joshua A Barocas, Laura F White et al.•American Journal of Public Health•2018

Obras citantes distintas33
Citações por ano11
Intervalo de citações2023 - 2026 (4)
Velocidade de citaçãocurrent
Altamente citadoNão
Tipos de citaçãoNeutras: 33
Ethnos_APP • Projeto Open Source • Licença MIT • Frontend v2.0.0 • Privacidade e Cookies • Documentação da API: api.ethnos.app/docs • Código da API: GitHub • DOI: 10.5281/zenodo.17049435 • Código do Frontend: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae